Ganglioside GM2 N‐acetyl‐ß‐D‐gafactosaminidase and asialo GM2 (GA2) N‐acetyl‐ß‐D‐galactosaminidase; studies in human skin fibroblasts
10.1111/j.1399-0004.1977.tb01296.x
Crossref journal-article
Wiley
Clinical Genetics (311)
Abstract

Ganglioside GM2 and its asialo‐derivative, GA2 were radiolabeled in their N‐acetyl‐D‐galactosaminyl moieties by oxidation with galactose oxidase and reduction with tritiated sodium borohydride. Specific activities of 6 × 104 dpm/nmol (GM2) and 1.8 × 106 dpm/nmol (GA2) were achieved. About 98% of the label was in N‐acetyl‐D‐galactosamine. Using these substrates, an assay was developed for GM2‐N‐acetyl‐β‐D‐galactosaminidase (E.C.3.2.1.30) and GA2‐N‐acetyl‐β‐D‐galactosaminidase (E.C.3.2.1.30) activities in human cultured skin fibroblasts. The products of the GM2 cleaving reaction were identified as N‐acetylgalactosamine and ganglioside GM3‐ Both GM2 and GA2 cleaving activities were stimulated about 5‐fold by purified sodium taurocholate, and this stimulation was inhibited by neutral detergents, lipids and albumin at low concentrations. Addition of various salts, reducing agents and a protein activator factor from human liver of Li et al. (1973) did not stimulate GM2‐N‐acetyl‐β‐D‐galactosaminidase activity beyond that found with sodium taurocholate. Under optimal conditions, control fibroblast supernates cleaved ganglioside GM2 at a rate of 3.7 nmol/mg protein/h compared to 1100 for GA2‐N‐acetyl‐β‐D‐galactosaminidase and 4700 for 4‐methylumbelliferyl‐N‐acetyl‐β‐D‐glucosaminidase. Supernates from two patients with Tay‐Sachs disease had markedly reduced activity levels for GM2‐N‐acetyl‐β‐D‐galactosaminidase but not for the other two substrates. Supernates from two patients with Sandhoff's disease had reduced activities for all three substrates. A supernate from one patient with juvenile GM2 gangliosidosis cleaved GM2 at a somewhat faster rate than those from Tay‐Sachs or Sandhoff's patients. Two healthy adult women with markedly reduced hexosaminidase A activities using 4MU‐N‐acetyl‐β‐D‐glucosaminide as substrate had approximately half‐normal activities using GM2 as substrate. A patient with the Tay‐Sachs phenotype but with a partial deficiency of hexosaminidase A using the 4‐MU substrate had a profound deficiency using GM2 as substrate. In such unusual hexosaminidase mutants, assays using GM2 as substrate are better indicators of phenotype than those using synthetic substrates.

Bibliography

O’Brien, J. S., Norden, A. G. W., Miller, A. L., Frost, R. G., & Kelly, T. E. (1977). Ganglioside GM2 N‐acetyl‐ß‐D‐gafactosaminidase and asialo GM2 (GA2) N‐acetyl‐ß‐D‐galactosaminidase; studies in human skin fibroblasts. Clinical Genetics, 11(2), 171–183. Portico.

Authors 5
  1. John S. O'Brien (first)
  2. Anthony G. W. Norden (additional)
  3. Arnold L. Miller (additional)
  4. Russel G. Frost (additional)
  5. Thaddeus E. Kelly (additional)
References 32 Referenced 30
  1. 10.1016/S0021-9258(19)41817-6 / J. biol. Chem. / Heterogeneity of human hepatic N‐acetyl‐β‐D‐hexosaminidase A activity toward natural glycolipid substrates by Bach G. (1975)
  2. 10.1136/adc.48.10.775
  3. 10.1111/j.1399-0004.1976.tb01609.x
  4. 10.1016/0006-291X(69)90947-4
  5. 10.1203/00006450-197210000-00002
  6. 10.1016/S0021-9258(19)43319-X / J. biol. Chem. / Hydrolysis of Tay‐Sachs ganglioside by β‐hexosaminidase A of human liver and urine by Li Y.‐T. (1973)
  7. 10.1016/S0021-9258(19)52451-6
  8. {'key': 'e_1_2_1_9_1', 'first-page': '287', 'article-title': 'Apparent deficiency of hexosaminidase A in healthy members of a family with Tay‐Sachs disease', 'volume': '25', 'author': 'Navon R.', 'year': '1973', 'journal-title': 'Amer. J. hum. Genet.'} / Amer. J. hum. Genet. / Apparent deficiency of hexosaminidase A in healthy members of a family with Tay‐Sachs disease by Navon R. (1973)
  9. 10.1016/0003-9861(73)90465-7
  10. 10.1016/S0022-2275(20)40217-2
  11. 10.1016/S0022-2275(20)39619-X / J. Lipid Res. / Lipid composition of the normal human brain: gray matter, white matter and myelin by O'Brien J. S. (1965)
  12. 10.1001/archpedi.1965.02090020340014
  13. 10.1126/science.165.3894.698
  14. 10.1016/S0022-3476(70)80096-8
  15. {'key': 'e_1_2_1_16_1', 'first-page': '55', 'article-title': 'Ganglioside GM2 storage diseases: hexosaminidase deficiencies in cultured fibroblasts', 'volume': '23', 'author': 'Okada S.', 'year': '1971', 'journal-title': 'Amer. J. hum. Genet'} / Amer. J. hum. Genet / Ganglioside GM2 storage diseases: hexosaminidase deficiencies in cultured fibroblasts by Okada S. (1971)
  16. 10.1016/0006-8993(69)90124-3
  17. 10.1016/0014-5793(70)80564-6
  18. 10.1111/j.1471-4159.1971.tb00204.x
  19. 10.1515/bchm2.1971.352.2.1119
  20. {'key': 'e_1_2_1_21_1', 'first-page': '345', 'volume-title': 'Total hexosaminidase deficiency in Tay‐Sachs disease (variant O). Lysosomes and Storage Diseases', 'author': 'Sandhoff K.', 'year': '1973'} / Total hexosaminidase deficiency in Tay‐Sachs disease (variant O). Lysosomes and Storage Diseases by Sandhoff K. (1973)
  21. Scott C. R.&J. S.O'BrienUnpublished data.
  22. 10.1093/oxfordjournals.jbchem.a130418
  23. 10.1016/0076-6879(66)08005-4
  24. 10.1016/S0021-9258(19)42793-2 / Purification and properties. J. biol. Chem. / Studies of human β‐D‐N‐acetylhexosaminidases I by Srivastava S. K. (1974)
  25. 10.1212/WNL.20.9.848
  26. 10.1016/S0022-2275(20)39375-5
  27. 10.1016/S0021-9258(19)44563-8 / J. biol. Chem. / The catabolism of Tay‐Sachs ganglioside in rat brain lysosomes by Tallman J. F. (1972)
  28. 10.1172/JCI107045
  29. 10.1038/252254a0
  30. {'key': 'e_1_2_1_31_1', 'first-page': '372', 'article-title': 'Absence of β‐N‐acetyl‐D‐hexosaminidase A activity in a healthy woman', 'volume': '25', 'author': 'Vidgoff J.', 'year': '1973', 'journal-title': 'Amer. J. hum. Genet.'} / Amer. J. hum. Genet. / Absence of β‐N‐acetyl‐D‐hexosaminidase A activity in a healthy woman by Vidgoff J. (1973)
  31. 10.1016/0003-9861(72)90427-4
  32. 10.1111/j.1471-4159.1968.tb05920.x
Dates
Type When
Created 15 years, 1 month ago (July 18, 2010, 5:34 p.m.)
Deposited 1 year, 9 months ago (Nov. 10, 2023, 3:27 p.m.)
Indexed 1 year, 9 months ago (Nov. 23, 2023, 2:38 p.m.)
Issued 48 years, 7 months ago (Feb. 1, 1977)
Published 48 years, 7 months ago (Feb. 1, 1977)
Published Online 17 years, 4 months ago (April 23, 2008)
Published Print 48 years, 7 months ago (Feb. 1, 1977)
Funders 0

None

@article{O_Brien_1977, title={Ganglioside GM2 N‐acetyl‐ß‐D‐gafactosaminidase and asialo GM2 (GA2) N‐acetyl‐ß‐D‐galactosaminidase; studies in human skin fibroblasts}, volume={11}, ISSN={1399-0004}, url={http://dx.doi.org/10.1111/j.1399-0004.1977.tb01296.x}, DOI={10.1111/j.1399-0004.1977.tb01296.x}, number={2}, journal={Clinical Genetics}, publisher={Wiley}, author={O’Brien, John S. and Norden, Anthony G. W. and Miller, Arnold L. and Frost, Russel G. and Kelly, Thaddeus E.}, year={1977}, month=feb, pages={171–183} }